Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 702 | $427,152,584 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 39 | 828.54 | 32,313 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 11 | 827.65 | 9,104 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 4 | 826.58 | 3,306 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 18 | 825.53 | 14,860 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 6 | 824.59 | 4,948 | D |
02 Nov 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Nov 2023 | Sale | 1,000 | 783.91 | 783,910 | D |
17 Oct 2023 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | ZOGHBI HUDA Y | Director | 13 Oct 2023 | Sale | 1,000 | 850 | 850,000 | D |
03 Oct 2023 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 02 Oct 2023 | Sale | 1,038 | 827 | 858,426 | D |
06 Sep 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Sep 2023 | Sale | 250 | 834.55 | 208,638 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 23 Aug 2023 | Sale | 223 | 844 | 188,212 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 500 | 841.05 | 420,525 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 6,450 | 840.65 | 5,422,192 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 3,032 | 839.45 | 2,545,212 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 1,998 | 838.6 | 1,675,523 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 300 | 837.92 | 251,376 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 2,534 | 844.27 | 2,139,380 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 759 | 843.31 | 640,072 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 617 | 842.66 | 519,921 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 363 | 841.15 | 305,337 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 46 | 840.74 | 38,674 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 148 | 839.28 | 124,213 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 667 | 838.37 | 559,193 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 300 | 837.53 | 251,259 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 625 | 836.32 | 522,700 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 138 | 835.67 | 115,322 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 22 Aug 2023 | Sale | 782 | 842.16 | 658,569 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 22 Aug 2023 | Sale | 4,574 | 841.41 | 3,848,609 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 22 Aug 2023 | Sale | 6,309 | 840.53 | 5,302,904 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 21 Aug 2023 | Sale | 853 | 829 | 707,137 | D |
11 Aug 2023 16:13 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 10 Aug 2023 | Sale | 853 | 789 | 673,017 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 1 | 744.66 | 745 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 2 | 741.42 | 1,483 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 3 | 740.52 | 2,222 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 5 | 739.63 | 3,698 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 10 | 738.45 | 7,384 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 17 | 737.5 | 12,538 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 16 | 736.64 | 11,786 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 22 | 735.55 | 16,182 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 18 | 734.56 | 13,222 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 4 | 733.51 | 2,934 | D |
03 Aug 2023 16:25 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Aug 2023 | Sale | 2 | 732.76 | 1,466 | D |
03 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Aug 2023 | Sale | 250 | 744.66 | 186,165 | D |
06 Jul 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Jul 2023 | Sale | 250 | 710.09 | 177,522 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 1 | 720.15 | 720 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 11 | 719.36 | 7,913 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 12 | 718.71 | 8,625 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 22 | 717.57 | 15,787 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 29 | 716.74 | 20,785 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 7 | 715.23 | 5,007 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 10 | 714.65 | 7,146 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 6 | 713.82 | 4,283 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 1 | 711.95 | 712 | D |
06 Jul 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jul 2023 | Sale | 1 | 710.09 | 710 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 7 | 738.35 | 5,168 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 17 | 737.52 | 12,538 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 31 | 736.4 | 22,828 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 12 | 735.42 | 8,825 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 10 | 734.62 | 7,346 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 2 | 733.61 | 1,467 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 10 | 732.49 | 7,325 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 9 | 731.49 | 6,583 | D |
02 Jun 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Jun 2023 | Sale | 2 | 730.03 | 1,460 | D |
02 Jun 2023 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Jun 2023 | Sale | 250 | 736 | 184,000 | D |
03 May 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2023 | Sale | 15 | 808.11 | 12,122 | D |
03 May 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2023 | Sale | 17 | 807.5 | 13,728 | D |
03 May 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2023 | Sale | 15 | 806.53 | 12,098 | D |
03 May 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2023 | Sale | 5 | 805.34 | 4,027 | D |
03 May 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2023 | Sale | 2 | 804.51 | 1,609 | D |
03 May 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2023 | Sale | 30 | 803.58 | 24,107 | D |
03 May 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2023 | Sale | 16 | 802.67 | 12,843 | D |
24 Apr 2023 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 21 Apr 2023 | Sale | 3,070 | 798.42 | 2,451,149 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 6 | 823.34 | 4,940 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 9 | 822.37 | 7,401 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 1 | 821.61 | 822 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 5 | 820.55 | 4,103 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 32 | 819.48 | 26,223 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 27 | 818.47 | 22,099 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 13 | 817.49 | 10,627 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 7 | 816.58 | 5,716 | D |
05 Apr 2023 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Apr 2023 | Sale | 1,100 | 818.8 | 900,680 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 31 | 826.36 | 25,617 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 243 | 825.37 | 200,565 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 157 | 824.54 | 129,453 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 181 | 823.6 | 149,072 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 128 | 822.67 | 105,302 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 142 | 821.4 | 116,639 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 115 | 820.85 | 94,398 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 10 | 818.81 | 8,188 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 7 | 830.01 | 5,810 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 4 | 829.16 | 3,317 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 13 | 825.59 | 10,733 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 4 | 824.3 | 3,297 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 18 | 822.57 | 14,806 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 48 | 821.39 | 39,427 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 50 | 820.46 | 41,023 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 39 | 819.47 | 31,959 | D |
27 Mar 2023 16:43 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 24 Mar 2023 | Sale | 1,240 | 818 | 1,014,320 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 400 | 810.3 | 324,120 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 700 | 806.47 | 564,529 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 47 | 805.55 | 37,861 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)